Home > Boards > US Listed > Medical - Healthcare >

China Infrastructure (CHNC)

CHNC RSS Feed
Add CHNC Price Alert      Hide Sticky   Hide Intro
Moderator: i_like_bb_stock, cash4, HNDRXX
Search This Board: 
Last Post: 5/12/2021 10:56:50 AM - Followers: 205 - Board type: Free - Posts Today: 2

 

https://www.pri.center/

Investor Relations - (817) 528-2475

On August 20, 2020, PRI was merged with and into the Company.

https://www.instagram.com/prinstitute101/

China Infrastructure Construction Corp. ---  Pink Current

https://www.otcmarkets.com/stock/CHNC/profile 


 

Acquisition of Precision Research Institute, LLC


On March 31, 2019, the Company acquired all of the outstanding units in Precision Research Institute, LLC, a Texas limited liability company (“PRI”) formed on May 18, 2016, from the Company’s president.

PRI is a Multi-Therapeutic, Dedicated Research Unit based in Houston, Texas. PRI brings multi-million-dollar contracts with the largest pharmaceutical companies in the world--like Abbvie, Samumed, Gilead, Intercept, Shire Pharmaceuticals, and more. President & CEO Elizabeth Hernandez says, “This acquisition of PRI, our second in the past year, now puts CHNC in the unique position of conducting its own clinical research trials. Which holds an important value the to the future of Medicine. CHNC is now in position to be the leader in the arena of Medical Clinical Trials. CHNC is in the process of becoming its very own Contract Research Organization (CRO) in the Industry. The looking forward to developing the future of Pharmaceutical, Biotechnology, and Pharmacovigilance Clinical Trials.
PRI has Phase I, II, and III clinical trial capabilities--a rare feat.
PRI’s facility is 4500 sq. ft. and currently has ongoing Phase II, III clinical trials, along with observational studies. 
Their fifteen active multi-million-dollar contracts is a great head start for CHNC. We look forward to expanding quickly!”

https://www.globenewswire.com/news-release/2019/10/21/1932484/0/en/China-Infrastructure-Construction-Corp-OTCPK-CHNC-is-Pleased-to-Announce-its-Acquisition-of-Precision-Research-Institute-LLC-PRI.html

The Company operates through three wholly owned subsidiaries. Through Hippocrates Direct Healthcare, LLC, a Texas limited liability company (“HDH”), formed on September 11, 2017, the Company offers concierge medicine at an affordable price through its membership-based model. Through Precision Research Institute, LLC, a Texas limited liability company (“PRI”) formed on May 18, 2016, the Company provides services in therapeutic areas of clinical trials, Through Pharmacology University, Inc., a Delaware corporation (“PUI”), incorporated on January 7, 2017, the Company provides educational systems focused on medicinal cannabis, in cities throughout the United States of America and six countries in Latin America. Information regarding the acquisition of these subsidiaries is as follows:

Acquisition of HDH and Recapitalization

On December 14, 2017, the Company, a wholly owned subsidiary of the Company and HDH entered into a Plan and Agreement of Merger (the “HDH Merger Agreement”), which provided that the subsidiary would be merged with and into HDH and that the two holders of units in HDH would receive shares of the Company’s common stock or cash, as each of them elected. On February 5, 2018 (the “Effective Date”), the merger was consummated, as the result of which HDH became the wholly owned subsidiary of the Company and the Company issued 4,500,000,000 shares of its common stock to one of the holders of units in HDH and made a promissory note for $9,500 in favor of the other, in accordance with their elections. Pursuant to the HDH Merger Agreement, the sole director, officer and majority stock-holder of the Company resigned from these positions, surrendered all of his shares of common stock in the Company and cancelled all of its indebtedness to him in consideration of a promissory note made by the Company in his favor in the principal amount of $420,000. (For information about this note, see Note 5.)

The merger whereby the Company acquired HDH was a reverse merger that resulted in a change of control, and has been accounted for as a recapitalization, whereunder HDH is the accounting acquirer. Accordingly, the historical financial statements prior to the Effective Date are those of HDH, have been prepared to give retroactive effect to the merger and represent the operations of HDH. The consolidated financial statements include the balance sheets of both companies at historical cost, the historical results of HDH and the results of the Company from the Effective Date. All share and pershare information in the accompanying unaudited consolidated financial statements and these notes has been retroactively restated to reflect the recapitalization.

https://twitter.com/hippocratesinc?lang=en

  
Acquisition of Pharmacology University, Inc.


On December 19, 2019, the Company acquired Pharmacology University, Inc., a Delaware corporation (“PUI”), pursuant to an Agreement and Plan of Merger, dated as of November 7, 2019, under which PUI was merged with and into the Company (the “PU Merger Agreement”). Pursuant to this agreement, the Company is obligated to issue, to the former holders of the common stock of PUI, 4,875,000,000 shares of the Company’s common stock and 2,000,000 shares of its Series A Convertible Preferred Stock. These shares are expected to be issued in the near future. When the shares are issued, a change of control will occur. In a separate agreement, Ms. Elizabeth Hernandez, the holder of 4,500,000,000 shares of Common Stock, and the president, sole director and controlling stockholder of the Company agreed to sell 3,000,000,000 such shares to the Company pursuant to a Stock Purchase Agreement, dated November 7, 2019, between the Company and her (the “Hernandez SPA”).
 

 

FaceBook - https://m.facebook.com/PrecisionResearchInstituteLLC/

Twitter - https://twitter.com/pri_center?s=11

Top of page B-11 https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content

Acquisition of PRi had taken place on 31 March, 2019

Acquisition of Precision Research Institute, LLC On March 31, 2019, the Company acquired all of the outstanding units in Precision Research Institute, LLC, a Texas limited liability company (“PRI”) formed on May 18, 2016, from the Company’s then president.

 Bottom of Page B-5 https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content

 

Merger with Pharmacology University, Inc.

 Merger with Pharmacology University, Inc. On December 19, 2019, Pharmacology University, Inc., a Delaware corporation (“PUI”), with and into the Company pursuant to an Agreement and Plan of Merger, dated as of November 7, 2019, under which PUI was merged with and into the Company (the “PU Merger Agreement”).

Bottom of Page B-5 https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content

https://www.facebook.com/pg/pharmacologyuniversity/about/?ref=page_internal

 

OTC DISCLOSURE & NEWS SERVICE

Source:  https://www.otcmarkets.com/stock/CHNC/news

 

OTC Markets - Disclosure

https://www.otcmarkets.com/stock/CHNC/disclosure

 

Transfer Agent:

Pacific Stock Transfer Company
6725 Via Austi Parkway,
Suite 300 Las Vegas,
NV 89119
Phone: (800) 785-7782
info@pacificstocktransfer.com

 

A/S  20,000,000,000   09/30/2020

O/S    8,732,256,416   09/30/2020

Restricted 7,023,693,512   09/30/2020

Unrestricted 1,708,562,904  09/30/2020

Held at DTC   1,380,650,255    09/30/2020  

Float   1,708,562,904  05/31/2020 Page 2 Number of shares in the Public Float: 1,708,562,904 as of the end of the Reporting Period and as of the date hereof:"" rel="nofollow ugc" target="_blank">https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content"; target="_blank" rel="nofollow ugc"> https://backend.otcmarkets.com/otcapi/company/financial-report/256967/content

 

CHNC
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PostSubject
#10684  Sticky Note Intensity, Determination and a Magical Unwavering Direction Transports cash4 04/15/21 10:50:26 AM
#9922  Sticky Note $CHNC MEGA NEWS: DEBT ELIMINATED, REVS INCREASED, HNDRXX 02/04/21 11:24:25 AM
#10781   GGII+ is a financial freedom freight train...I was crossball 05/12/21 09:52:11 AM
#10780   Are we financially free yet yawn jbnavy 05/11/21 01:31:38 PM
#10779   just waiting - watching to see if any crossball 05/11/21 10:17:48 AM
#10778   LOL what is this company doing jbnavy 05/11/21 09:16:55 AM
#10777   there's a chance...hoping not to have to torch crossball 05/10/21 10:37:39 AM
#10776   Hope we get some news this week jbnavy 05/09/21 06:49:25 PM
#10775   what is your def of a massive run? ChowChowDog 05/08/21 09:54:22 PM
#10774   .004 is the first leg...if it stabilize pps ursa 05/07/21 09:24:45 PM
#10773   but what good is .004?? ChowChowDog 05/07/21 08:24:21 PM
#10772   the bollinger bands are getting tighter....a technical bounce ursa 05/07/21 07:51:51 PM
#10771   at some point, they will have to burn crossball 05/06/21 09:25:37 PM
#10770   Hope chnc$ holds the 2s...jeez...volume is so pathetic ursa 05/06/21 08:50:14 PM
#10769   are the pretty people even showing up to crossball 05/06/21 11:50:41 AM
#10768   Let’s go jbnavy 05/05/21 03:46:54 PM
#10767   Lol, definitely primed for launch on some good PR... Honestup 05/05/21 11:57:12 AM
#10766   CHNC needs to release updates.....the management has not ursa 05/04/21 11:31:52 AM
#10765   Only about 800,000 shares to .0032! Honestup 05/03/21 10:32:35 AM
#10764   That sure would. I have no time limit 50 MIL STRONG 05/02/21 06:02:44 PM
#10763   ..coupled with Mark's release would be the cake. crossball 05/02/21 05:53:59 PM
#10762   Glad ya enjoyed the experience despite all the 50 MIL STRONG 05/02/21 05:49:36 PM
#10761   looking forward to CHNC this week. I crossball 05/02/21 05:46:17 PM
#10760   I landed in Bangkok at midnight then they crossball 05/02/21 05:44:32 PM
#10759   Nice! Home yet? 50 MIL STRONG 05/02/21 05:34:04 PM
#10758   Bangkok. crossball 05/02/21 05:33:10 PM
#10757   What country were ya in when the comment 50 MIL STRONG 05/02/21 03:35:07 PM
#10756   Nice movement on low volume... Honestup 04/30/21 02:08:41 PM
#10755   I can feel you....good, that I said that crossball 04/30/21 11:09:08 AM
#10754   these guys are into covid and marijuana products ursa 04/30/21 10:31:13 AM
#10753   note: concrete hardening is a good thing...means crossball 04/30/21 09:50:45 AM
#10752   is the concrete hardening from this company?...what do crossball 04/30/21 09:09:52 AM
#10751   That's because they put out the most idiotic, ChowChowDog 04/29/21 06:04:14 PM
#10750   Their PRs do nothing.... it goes to .0120 PennyPusher786 04/29/21 04:02:19 PM
#10749   Yes..the mms are ready to let loose imho...so ursa 04/29/21 02:17:26 PM
#10748   Level 2 looks nice and thin too! Honestup 04/29/21 01:58:32 PM
#10747   this is a pink current, share buy back, ursa 04/29/21 12:47:09 PM
#10746   I couldn't have said it better myself! Honestup 04/29/21 12:01:35 PM
#10745   About time they release a Juicy PR...man waiting ursa 04/29/21 11:54:53 AM
#10744   Added here today... I'll try for some more tomorrow... Honestup 04/28/21 05:18:34 PM
#10743   I remember the first time this one popped... Honestup 04/28/21 03:02:54 PM
#10742   Wow! Look at that volume... lol Honestup 04/28/21 02:36:43 PM
#10741   green close crossball 04/27/21 03:09:51 PM
#10740   OK Nancy, whatever you say lol NiteShift 04/27/21 01:09:01 PM
#10739   Damn Karen, calm down...lol. Doubleday 04/27/21 11:50:31 AM
#10738   as of today...not with this stock. For crossball 04/27/21 11:05:18 AM
#10737   How about now? StockFOXXX 04/27/21 11:03:08 AM
#10736   okidoke crossball 04/27/21 10:33:29 AM
#10735   They merged, I'm pretty sure the name is cash4 04/27/21 10:30:13 AM
#10734   China Infrastructure Construction is their name currently..they have crossball 04/27/21 10:28:16 AM
#10733   I didn't understand a Fiing thing you said. cash4 04/27/21 10:24:11 AM
#10732   change the fn name...current name couldn't be farther crossball 04/27/21 10:22:00 AM
PostSubject
Consent Preferences